StockData
Transcode Therapeutics, Inc. logo

Transcode Therapeutics, Inc. (RNAZ) bonds

RNAZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$1.41+0.06 (+4.44%)

Close on Nov 17, 2026Market cap $1.43MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Transcode Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Transcode Therapeutics's 10-Q for the period ended Apr 16, 2026

IssueAmount issued
First convertible note
Convertible
$1.00M
Note Eight$100.00K
Note Eleven$40.00K
Note Five$50.00K
Note Four$50.00K
Note Fourteen$50.00K
Note Nine$100.00K
Note One$500.00K
Note Seven$50.00K
Note Six$50.00K
Note Ten$1.00M
Note Thirteen$50.00K
Note Three$100.00K
Note Twelve$50.00K
Note Two$50.00K
Notes Payable Convertible
Convertible
$6.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?